Turning on Nrf2 translation for chronic liver disease
开启 Nrf2 翻译治疗慢性肝病
基本信息
- 批准号:9326288
- 负责人:
- 金额:$ 18.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-01 至 2018-07-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAmericanAntioxidantsApigeninBindingBinding ProteinsCellsCharacteristicsChemicalsCodon NucleotidesDevelopmentDietDiseaseFirefly LuciferasesFlavonoidsGenetic TranslationHalf-LifeHepatocyteHumanLaboratoriesLibrariesLiver diseasesLuc GeneLuciferasesLuteolinMessenger RNAMutateNonesterified Fatty AcidsOpen Reading FramesOxidative StressPathogenesisPhysiologicalPhytochemicalPlayPopulationPreventionProcessProductionPropertyProteinsProteomicsPublic HealthQuercetinRNA-Protein InteractionRegulationRegulatory ElementReporterReporter GenesResearchRoleSignal TransductionSystemTechniquesTestingToxic effectTranslationsWorkbasechronic liver diseasedesigndietary supplementsgenetic regulatory proteinhigh rewardhigh riskmolecular targeted therapiesnon-alcoholic fatty livernovelnuclear factor-erythroid 2preventpublic health relevanceresponsetranscription factor
项目摘要
DESCRIPTION (provided by applicant): This study is designed to characterize the mechanism that allows flavonoids to regulate the translation of Nuclear factor erythroid 2-related factor 2 (Nrf2) - an important molecular target for the treatment or prevention of chronic diseases of the liver. Oxidative stress is a process involved in the genesis and perpetuation of non-alcoholic fatty liver disease (NAFLD), the most prevalent liver disease affecting up to 30% of the American population. Nrf2 is the master regulator of the cell's owns defense system against oxidative conditions, and an extensive body of research indicates that increasing the activity of Nrf2 with phytochemicals could be a viable strategy to ameliorate the progression of NAFLD. We recently discovered a novel mechanism regulating the translation of Nrf2 under physiological conditions in human cells. The mechanism, which is not fully understood, is dependent on a portion of the mRNA sequence located in the open reading frame, and its inhibitory effect is alleviated if the sequence is mutated with synonym codon substitutions. More importantly, this portion of the sequence is able to prevent the translation of the reporter gene Firefly Luciferase. Subsequently, we were able to use this luciferase construct as a reporter to validate the hypothesis that some known natural antioxidants that increase the Nrf2 activity might work by promoting its translation. We identified the flavonoid Apigenin as a potent inducer of the translation of Nrf2 and we confirmed this via multiple techniques. We also found a similar property for other flavonoids such as Quercetin and Luteolin. The challenge now is to identify the protein targets that allow these flavonoids to activate the translation of Nrf2 and also see if
other flavonoids present in the human diet share this property. To execute this, we propose performing RNA-protein interaction studies based on cutting edge proteomics techniques and also using the Luciferase reporter to screen a library of 500 flavonoids.
描述(由适用提供):本研究旨在表征允许类黄酮调节核因子红细胞2相关因子2(NRF2)的转化的机制 - 一种重要的分子靶标,用于治疗或预防肝脏的慢性疾病。氧化应激是参与非酒精性脂肪肝疾病(NAFLD)的生成和永久化的过程,影响高达30%NRF2的最普遍的肝病是该细胞自身防御系统针对氧化条件的主要调节剂,并且研究的广泛体系表明,NRF2的活性可能会导致NRF2的活性促进生理策略。我们最近发现了一种新的机制,该机制在人类细胞的生理条件下衡量了NRF2的翻译。该机制尚未完全理解,取决于位于开放式阅读框架中的mRNA序列的一部分,如果序列被同义词密码子取代突变,则可以减轻其抑制作用。更重要的是,序列的这一部分能够防止报告基因萤火虫荧光素酶的翻译。随后,我们能够使用这种荧光素酶构建体作为记者,以验证以下假设:一些已知的自然抗氧化剂增加了NRF2活性,可以通过促进其翻译来起作用。我们确定了类黄酮替代蛋白是NRF2翻译的潜在诱导剂,并通过多种技术证实了这一点。我们还发现了其他类黄酮(例如槲皮素和叶黄素)的类似特性。现在的挑战是确定允许这些类黄酮激活NRF2的翻译的蛋白质靶标,也看看是否是否
人类饮食中存在的其他类黄酮具有这种特性。为了执行此操作,我们建议基于最前沿蛋白质组学技术进行RNA-蛋白相互作用研究,并使用荧光素酶报告基因筛选500个类黄酮的库。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
CRISPR/Cas9-Based Screening of FDA-Approved Drugs for NRF2 Activation: A Novel Approach to Discover Therapeutics for Non-Alcoholic Fatty Liver Disease.
- DOI:10.3390/antiox12071363
- 发表时间:2023-06-29
- 期刊:
- 影响因子:7
- 作者:Li, James;Arest, Sandra;Olszowy, Bartlomiej;Gordon, John;Barrero, Carlos A.;Perez-Leal, Oscar
- 通讯作者:Perez-Leal, Oscar
Identification of Inhibitors of Tubulin Polymerization Using a CRISPR-Edited Cell Line with Endogenous Fluorescent Tagging of β-Tubulin and Histone H1.
- DOI:10.3390/biom13020249
- 发表时间:2023-01-29
- 期刊:
- 影响因子:5.5
- 作者:
- 通讯作者:
Multiplex Gene Tagging with CRISPR-Cas9 for Live-Cell Microscopy and Application to Study the Role of SARS-CoV-2 Proteins in Autophagy, Mitochondrial Dynamics, and Cell Growth.
- DOI:10.1089/crispr.2021.0041
- 发表时间:2021-12
- 期刊:
- 影响因子:0
- 作者:Perez-Leal O;Nixon-Abell J;Barrero CA;Gordon JC;Oesterling J;Rico MC
- 通讯作者:Rico MC
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Oscar Perez其他文献
Oscar Perez的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Oscar Perez', 18)}}的其他基金
CRISPR-based genome tagging of iPS Cells for stain-free multicolor live cell analysis
基于 CRISPR 的 iPS 细胞基因组标记,用于免染色多色活细胞分析
- 批准号:
10621169 - 财政年份:2022
- 资助金额:
$ 18.41万 - 项目类别:
CRISPR-based genome tagging of iPS Cells for stain-free multicolor live cell analysis
基于 CRISPR 的 iPS 细胞基因组标记,用于免染色多色活细胞分析
- 批准号:
10353812 - 财政年份:2022
- 资助金额:
$ 18.41万 - 项目类别:
Turning on Nrf2 translation for chronic liver disease
开启 Nrf2 翻译治疗慢性肝病
- 批准号:
8873073 - 财政年份:2015
- 资助金额:
$ 18.41万 - 项目类别:
相似海外基金
Synergistically Target Mitochondria for Heart Failure Treatment
协同靶向线粒体治疗心力衰竭
- 批准号:
10584938 - 财政年份:2023
- 资助金额:
$ 18.41万 - 项目类别:
Iron homeostasis and monocyte differentiation in patients with chronic kidney disease
慢性肾病患者的铁稳态和单核细胞分化
- 批准号:
10648527 - 财政年份:2023
- 资助金额:
$ 18.41万 - 项目类别:
Racial disparities of open angle glaucoma: A study of mitochondria and oxidative stress in human trabecular meshwork
开角型青光眼的种族差异:人类小梁网线粒体和氧化应激的研究
- 批准号:
10735655 - 财政年份:2023
- 资助金额:
$ 18.41万 - 项目类别:
Regulators of Photoreceptor Aerobic Glycolysis in Retinal Health and Disease
视网膜健康和疾病中光感受器有氧糖酵解的调节因子
- 批准号:
10717825 - 财政年份:2023
- 资助金额:
$ 18.41万 - 项目类别:
Identification of Trichomonas vaginalis resistance targets to inform future drug development
确定阴道毛滴虫耐药靶标,为未来药物开发提供信息
- 批准号:
10462312 - 财政年份:2023
- 资助金额:
$ 18.41万 - 项目类别: